Description: Mayne Pharma Group Limited is a specialty pharmaceutical company, which focuses on applying its drug delivery capability to commercialize branded and generic pharmaceuticals. The Company also provides contract development and manufacturing services. It operates in four segments: Generic Products (GPD), Specialty Brands (SBD), Metrics Contract Services (MCS) and Mayne Pharma International (MPI). The GPD segment is engaged in the manufacture and distribution of generic pharmaceutical products in the United States. The SBD segment markets and distributes specialty branded pharmaceutical products in the United States. The MCS segment is engaged in the provision of contract analytical and pharmaceutical development services to third-party customers in the United States. The MPI segment is engaged in Australian manufacture and sale of branded and generic pharmaceutical product globally and provision of contract manufacturing services to third-party customers within Australia.
Home Page: www.maynepharma.com
MYX Technical Analysis
1538 Main North Road
Salisbury South,
SA
5106
Australia
Phone:
61 8 8209 2666
Officers
Name | Title |
---|---|
Mr. Shawn Patrick O'Brien B.Sc | CEO, MD & Director |
Mr. Aaron Gray | Chief Financial Officer |
Ms. Lisa Pendlebury | VP of Investor Relations & Communications |
Ms. Kimberly Parker J.D. | Exec. VP & Gen. Counsel |
Mr. Brant Schofield | Exec. VP of Corp. Devel. |
Dr. Andrew O. Herdman Ph.D. | VP of Group HR |
Mr. Stefan J. Cross | Pres of International Operations |
Mr. Daniel Moore | Exec. VP of Specialty Products & Patient Solutions |
Mr. Gerard G. Nahum M.D. | Chief Medical Officer |
Mr. Hemanshu N. Pandya | Sr. VP & Head of Generic Product Division |
Exchange: AU
Country: AU : Australia
Currency: Australian Dollar (A$)
GIC Sector: | Health Care |
---|---|
GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
GIC Industry: | Pharmaceuticals |
GIC Sub-Industry: | Pharmaceuticals |
Forward PE: | 285.7143 |
---|---|
Trailing PE: | 0 |
Price-to-Book MRQ: | 0.6161 |
Price-to-Sales TTM: | 0.8396 |
IPO Date: | 2007-06-29 |
Fiscal Year End: | June |
Full Time Employees: | 0 |